These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34929213)

  • 1. SOX9 acts downstream of YAP to decide liver cell fate and tumor types.
    Ding WX; Sancho-Bru P
    J Hepatol; 2022 Mar; 76(3):503-505. PubMed ID: 34929213
    [No Abstract]   [Full Text] [Related]  

  • 2. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis.
    Liu Y; Zhuo S; Zhou Y; Ma L; Sun Z; Wu X; Wang XW; Gao B; Yang Y
    J Hepatol; 2022 Mar; 76(3):652-664. PubMed ID: 34793870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
    Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G
    Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
    PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.
    Zhang Y; Guo X; Xiong L; Kong X; Xu Y; Liu C; Zou L; Li Z; Zhao J; Lin N
    FEBS Lett; 2012 Dec; 586(24):4362-70. PubMed ID: 23178713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.
    Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z
    Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
    Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C
    Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
    Leung CO; Mak WN; Kai AK; Chan KS; Lee TK; Ng IO; Lo RC
    Oncotarget; 2016 May; 7(20):29371-86. PubMed ID: 27105493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
    Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
    Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model.
    Anfuso B; El-Khobar KE; Ie SI; Avellini C; Radillo O; Raseni A; Tiribelli C; Sukowati CHC
    Sci Rep; 2018 Sep; 8(1):13168. PubMed ID: 30177788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma.
    Chen Y; Qian B; Sun X; Kang Z; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y
    Cancer Lett; 2021 Feb; 499():243-254. PubMed ID: 33246092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
    Kawai T; Yasuchika K; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Komori J; Hatano E; Kawaguchi Y; Uemoto S
    Sci Rep; 2016 Jul; 6():30489. PubMed ID: 27457505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
    Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
    World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of shRNA-Mediated SOX9 Inhibition on Cell Proliferation and Apoptosis in Human HCC Cell Line Hep3B Mediated by Ultrasound-Targeted Microbubble Destruction (UTMD).
    Xue Y; Yang G; Wang C; Li X; Du G
    Cell Biochem Biophys; 2015 Nov; 73(2):553-558. PubMed ID: 27352352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical and Prognostic Implications of Pluripotent Stem Cell Markers Expression and Their Correlation with the WNT signal pathway in Hepatocellular Carcinoma.
    Osman NAA; Khalil AI; Yousef RK
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2961-2970. PubMed ID: 33112555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
    LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
    Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B; Liu D; Yang P; Li HY; Wang D
    Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.
    Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G
    Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Mimics Effects of Glypican-3 on CD81 and Promotes Development of Hepatocellular Carcinomas via Activation of Hippo Pathway in Hepatocytes.
    Xue Y; Mars WM; Bowen W; Singhi AD; Stoops J; Michalopoulos GK
    Am J Pathol; 2018 Jun; 188(6):1469-1477. PubMed ID: 29577937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.